What is Bakhu Holdings Financial Strength?
Bakhu Holdings has the Financial Strength Rank of 4.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
Bakhu Holdings did not have earnings to cover the interest expense.
As of today, Bakhu Holdings's Altman Z-Score is 0.00.
Competitive Comparison of Bakhu Holdings's Financial Strength
For the Drug Manufacturers - Specialty & Generic subindustry, Bakhu Holdings's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bakhu Holdings's Financial Strength Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bakhu Holdings's Financial Strength distribution charts can be found below:
* The bar in red indicates where Bakhu Holdings's Financial Strength falls into.
Bakhu Holdings Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Bakhu Holdings's Interest Expense for the
months ended in Jan. 2024 was $-0.08 Mil. Its Operating Income for the
months ended in Jan. 2024 was $-0.37 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $7.63 Mil.
Bakhu Holdings's Interest Coverage for the quarter that ended in Jan. 2024 is
| Bakhu Holdings did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Bakhu Holdings's Debt to Revenue Ratio for the quarter that ended in Jan. 2024 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Bakhu Holdings has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bakhu Holdings (Bakhu Holdings) Business Description
Traded in Other Exchanges
N/A
Address
One World Trade Center, Suite 130, Long Beach, CA, USA, 90831
Bakhu Holdings Corp is a development stage company engaged in the production, manufacturing, and sale of cannabis and byproducts. The company also provides cannabis-related research, teaching and education for both medical and other purposes, and all medical uses and applications of cannabis, within the Territory.
Executives
| Tom Vaknin |
director |
SPYROU KYPRIANOU 16, PYGROS / LIMMASOL G4 4529 |
| Moshe Morgenstern |
director |
MENACHEM BEGIN 88, PETAH TIKVAH/CENTRAL DISTRICT L3 49504 |
| Geoffrey Robert Dixon |
10 percent owner |
16 SHOBY LANE, GRIMSTON X0 LE14 3DD |
| Michael Richard Hawthorne |
officer: Deputy CEO |
20 LARKSBOROUGH AVENUE, COUNTY DOWN X0 BT23 8SU |
| Garcia La Sienra Garcia Juan Carlos |
director, officer: CFO |
3 SHANEWOOD CT, THE WOODLANDS TX 77382 |
| Sagi Rami Rozen |
director |
HOUSE NUMBER 8, 8 AGIAS TRIADAS STREET (MOUTTAGIAKA), LIMASSOL G4 4527 |
| Cell Science Holding, Ltd. |
10 percent owner |
PANTELI KATELARI 18A, AGIOS IOANNIS, LIMASSOL G4 3012 |
| Mentone, Ltd. |
10 percent owner |
3 COPLOW CRESCENT, SYSTON, LEICESTER X0 LE7 2JE |
| Inter-m Traders Fz, Lle |
10 percent owner |
18A PENTELI KATELARI, LIMASSOL G4 3021 |
| Thomas K Emmitt |
director, officer: President, CEO and Secretary |
ONE WORLD TRADE CENTER, SUITE 130, LONG BEACH CA 90831 |
| Aristotle Popolizio |
director |
206 PASSAIC AVENUE, ROSELAND NJ 07068 |
| Evripides Drakos |
director |
139C GLOUCESTER TERRACE, LANCASTER GATE, LONDON X0 W2 6DX |
| Peter Whitton |
director |
3 COPLOW CRESCENT, SYSTON LEICESTER X0 LE7 2JE |
| Oz Corp |
10 percent owner |
24328 VERMONT AVENUE, SUITE 300, HARBOR CITY CA 90710 |
Bakhu Holdings (Bakhu Holdings) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BKUH has been successfully added to your